Middle Ear Pressure Therapy Aids Vertigo Symptoms
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 4, 2023 -- Middle ear pressure therapy (MEPT) using the EFET01 device effectively controls vertigo symptoms with Meniere disease and delays endolymphatic hydrops (DEH), according to a study published online Nov. 23 in Acta Oto-Laryngologica.
Do Tram Anh, from the University of Toyama in Japan, and colleagues examined the two-year effects of the EFET01 device on reducing vertigo attacks and improving hearing of Meniere disease and DEH patients. The analysis included 32 patients with Meniere disease and two with DEH treated by MEPT with the EFET01 device from December 2018 to April 2021.
The researchers found that compared with six months before treatment, the frequency of vertigo attacks significantly decreased in both Meniere disease and DEH patients. Additionally, hearing level remained stable in the majority of patients 18 to 24 months after treatment.
"In conclusion, we found that MEPT with the EFET01 device showed efficacy in improving the symptoms of vertigo in patients with Meniere disease and DEH, and no severe hearing impairment was observed," the authors write. "Therefore, the EFET01 device could be considered a viable treatment option before attempting any invasive treatment in therapeutic strategies for Meniere disease."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Triple Semicircular Canal Occlusion + Endolymphatic Sac Decompression Alleviates Vertigo
WEDNESDAY, June 5, 2024 -- Triple semicircular canal occlusion combined with endolymphatic sac decompression (ESD) may be an effective treatment option for managing frequent...
Cochlear Implants Aid Meniere Disease Outcomes
TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...
No Causal Association Seen for Meniere Disease, Migraine
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.